This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Other. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,659 Years Active: 2021
Title: Xianjie Chen: Innovator in Kinase Inhibitory Compounds
Introduction
Xianjie Chen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with kinase inhibitory activity. His work is aimed at addressing diseases related to CDK kinase, including various forms of cancer.
Latest Patents
Xianjie Chen holds a patent for a compound with kinase inhibitory activity, which includes a preparation method and its uses. The invention provides a compound represented by general formulas (I) or (II), along with its pharmaceutically acceptable salts, isomers, mixtures, solvates, polymorphs, stable isotope derivatives, or prodrugs. This compound exhibits CDK kinase inhibitory activity, making it a potential treatment for diseases associated with CDK kinase.
Career Highlights
Throughout his career, Xianjie Chen has worked with various companies, including Fuyao. His expertise in the field has allowed him to contribute to innovative solutions in pharmaceutical development.
Collaborations
Xianjie Chen has collaborated with notable individuals such as Fuyao Zhang and Weijun Fang, enhancing the impact of his work through teamwork and shared expertise.
Conclusion
Xianjie Chen's contributions to the field of kinase inhibitors highlight his role as an innovator in pharmaceutical research. His patent reflects a significant advancement in the treatment of diseases related to CDK kinase.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile